Published 2 days ago • loading... • Updated 1 day ago

RVNC Deadline: RVNC Investors Have Opportunity to Lead Revance Therapeutics, Inc. Securities Fraud Lawsuit

The Rosen Law Firm informs investors in Revance Therapeutics, Inc. About a March 4, 2025 deadline to become lead plaintiff in a securities fraud lawsuit.
Rosen Law Firm is reminding purchasers of Revance Therapeutics, Inc. Securities about a lead plaintiff deadline on March 4, 2025.
A class action lawsuit has been filed claiming Revance made false statements and failed to disclose business risks during the class period.
The lawsuit alleges these actions led to investor damages when the truth was revealed.

Insights by Ground AI

Does this summary seem wrong?

55 Articles

All

Left

Center

Right

winchesternewsgazette.com

+15 Reposted by 15 other sources

REGN Deadline: REGN Investors with Losses in Excess of $100K Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit

NEW YORK, March 2, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the "Class Period"),…

1 day ago

Read Full Article

Charleston Gazette-Mail

+38 Reposted by 38 other sources

RVNC Deadline: RVNC Investors Have Opportunity to Lead Revance Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, March 1, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Revance Therapeutics, Inc. (NASDAQ: RVNC) between February 29, 2024 and December 6, 2024, both dates inclusive (the "Class Period"),…

2 days ago·Charleston, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year